RK

Rajendra Kumar Karna

Active Director Director DIN 08804940
DIN 08804940 First appointment Jul 2020 Primary industry Trading
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2020
Shareholding value •••• Premium profile

About Rajendra Kumar Karna

Data last updated:

Rajendra Kumar Karna is a Director at Calista Pharmaceuticals Private Limited (since 2020). The company operates in Trading. Calista Pharmaceuticals Private Limited reported revenue of ₹2.4 Lakh (FY 2022).

DIN 08804940
Primary Designation Director
Industry Trading
First Appointment 22 Jul 2020
Oldest Company Age 6 yrs
Largest company Calista Pharmaceuticals Private Limited · ₹2.4 Lakh (FY 2022)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Jul 20202020₹2.4 Lakh (FY 2022)Active

Board colleagues of Rajendra Kumar Karna

NameDINCompanyDesignation
Dilip Kumar Das09776758Calista Pharmaceuticals Private LimitedAdditional Director

Directorship timeline

Open interactive timeline →
Calista Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajendra Kumar Karna

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajendra Kumar Karna

Rajendra Kumar Karna currently holds 1 directorship: Calista Pharmaceuticals Private Limited (Director, since 22 Jul 2020, revenue ₹2.4 Lakh (FY 2022)).

Rajendra Kumar Karna was first appointed on 22 Jul 2020 as Director at Calista Pharmaceuticals Private Limited.

The current boards of Rajendra Kumar Karna's companies include Dilip Kumar Das (Calista Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available